Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0000899243-19-001200

Chief Scientific Officer gave up 5,916 shares (to pay taxes)

  • Chief Scientific Officer acquired 15,562 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Vexler Vladimir Chief Scientific Officer 2019-01-11 Grant or award +15,562 23,390 D
Vexler Vladimir Chief Scientific Officer 2019-01-11 Shares withheld for taxes −5,916 $12.37 $73,181 17,474 D
Derivatives
Vexler Vladimir Chief Scientific Officer 2019-01-11 Grant or award · Stock Option (Right to Buy) +126,000 126,000 D
Loading xslF345X03/doc4.xml…